UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients

Breast cancer research and treatment, 2016-12, Vol.160 (3), p.439-446

2016

Volltextzugriff (PDF)

A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients

Clinical cancer research, 2015-03, Vol.21 (5), p.1207-1214

2015

Volltextzugriff (PDF)

Inhibition of RET activated pathways: novel strategies for therapeutic intervention in human cancers

Current pharmaceutical design, 2013-02, Vol.19 (5), p.864-882

2013

Volltextzugriff (PDF)

DNA Repair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes

The oncologist (Dayton, Ohio), 2013, Vol.18 (10), p.1063-1073

2013

Volltextzugriff (PDF)

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.333-343

2012

Volltextzugriff (PDF)

Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer

International journal of molecular sciences, 2017-01, Vol.18 (1), p.194-194

2017

Volltextzugriff (PDF)

Role of inflammation in obesity-related breast cancer

Current opinion in pharmacology, 2016-12, Vol.31, p.114-122

2016

Volltextzugriff (PDF)

Targeting microRNAs as key modulators of tumor immune response

Journal of experimental & clinical cancer research, 2016-06, Vol.35 (1), p.103-103, Article 103

2016

Volltextzugriff (PDF)

Progress in nonviral gene therapy for breast cancer and what comes next?

Expert opinion on biological therapy, 2017-05, Vol.17 (5), p.595-611

2017

Volltextzugriff (PDF)

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

Breast cancer research : BCR, 2016-12, Vol.18 (1), p.121-121, Article 121

2016

Volltextzugriff (PDF)

Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes

International journal of cancer, 2016-01, Vol.138 (1), p.87-97

2016

Volltextzugriff (PDF)

Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers

Current pharmaceutical design, 2012-12, Vol.19 (5), p.864-882

2012

Volltextzugriff (PDF)

Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: A review of the literature

Critical reviews in oncology/hematology, 2017-05, Vol.113, p.283-291

2017

Volltextzugriff (PDF)

Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer

The oncologist (Dayton, Ohio), 2016-09, Vol.21 (9), p.1063-1078

2016

Volltextzugriff (PDF)

Immune gene signatures in triple-negative breast cancers characterized by varying levels of chromosomal instability

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1096-1096

2017

Volltextzugriff (PDF)

An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes

British journal of cancer, 2018-04, Vol.118 (8), p.1107-1114

2018

Volltextzugriff (PDF)

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

Oncotarget, 2015-11, Vol.6 (35), p.37269-37280

2015

Volltextzugriff (PDF)

Targeting the microRNA-regulating DNA damage/repair pathways in cancer

Expert opinion on biological therapy, 2014-11, Vol.14 (11), p.1667-1683

2014

Volltextzugriff (PDF)

Abstract A118: CD103+/PD-1+ T-cells identify a subset of triple-negative breast cancer eligible for targeted checkpoint inhibition

Cancer immunology research, 2016-11, Vol.4 (11_Supplement), p.A118-A118

2016

Volltextzugriff (PDF)

Abstract 1958: Developing an online tool to validate survival-associated miRNAs utilizing expression data from 2,061 breast cancer patients

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1958-1958

2016

Volltextzugriff (PDF)

Prognostic factors and outcome of HER2+ breast cancer with CNS metastases

Future oncology (London, England), 2020-03, Vol.16 (7), p.269-279

2020

Volltextzugriff (PDF)

Clinical Relevance of the Immune Contexture and AXL Kinase in Triple-Negative Breast Cancer

Bottai, Giulia

2017

Volltextzugriff (PDF)

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers

Molecular oncology, 2014-05, Vol.8 (3), p.508-519

2014

Volltextzugriff (PDF)

Abstract P4-07-02: A large integrated-gene profiling analysis identifies prognostic microRNAs and correlated DNA repair genes in estrogen receptor positive and negative breast cancers

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P4-P4-07-02

2015

Volltextzugriff (PDF)

CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression

Disease markers, 2018-01, Vol.2018 (2018), p.1-9

2018

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(30)
Humans
(25)
Female
(18)
Oncology
(14)
Breast Cancer
(13)
Breast Neoplasms - Genetics
(9)
Endocrinology & Metabolism
(9)
Prognosis
(8)
Cancer
(7)
Gene Expression Regulation, Neoplastic
(7)
Breast Neoplasms - Pathology
(6)
Cancer Therapies
(6)
Gene Expression
(6)
Animals
(5)
Biomarkers, Tumor - Genetics
(5)
Male
(5)
Medical Prognosis
(5)
Micrornas - Genetics
(5)
Mutation
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients

A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients

Inhibition of RET activated pathways: novel strategies for therapeutic intervention in human cancers

DNA Repair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer

Role of inflammation in obesity-related breast cancer

Targeting microRNAs as key modulators of tumor immune response

Progress in nonviral gene therapy for breast cancer and what comes next?

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes

Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers

Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: A review of the literature

Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer

Immune gene signatures in triple-negative breast cancers characterized by varying levels of chromosomal instability

An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

Targeting the microRNA-regulating DNA damage/repair pathways in cancer

Abstract A118: CD103+/PD-1+ T-cells identify a subset of triple-negative breast cancer eligible for targeted checkpoint inhibition

Abstract 1958: Developing an online tool to validate survival-associated miRNAs utilizing expression data from 2,061 breast cancer patients

Prognostic factors and outcome of HER2+ breast cancer with CNS metastases

Clinical Relevance of the Immune Contexture and AXL Kinase in Triple-Negative Breast Cancer

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers

Abstract P4-07-02: A large integrated-gene profiling analysis identifies prognostic microRNAs and correlated DNA repair genes in estrogen receptor positive and negative breast cancers

CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression

Suchergebnisse filtern